TNF and COVID-19: These preliminary findings support a role for the blockade of TNF-α in the treatment of the COVID-19 inflammatory cascade, with possibilities extending to the use of other TNF treatments ((Infliximab, Adalimumab, Golimumab)/Fab′-PEG (Certolizumab) Fusion TNFR2-IgG1-Fc (Etanercept)) [146] (Table 1).